Medical imaging agents provider Lantheus Holdings files for a $125 million IPO

By Renaissance Capital,

Shutterstock photo

Lantheus Holdings, which sells medical imaging agents used in the diagnosis of cardiovascular diseases, filed on Tuesday with the SEC to raise up to $125 million in an initial public offering. The North Billerica, MA-based company, which was founded in 1956 and booked $286 million in sales for the 12 months ended March 31, 2014, plans to list on the NASDAQ under the symbol LNTH. Lantheus Holdings initially filed confidentially on March 25, 2014. Citi and Jefferies are the joint bookrunners on the deal. No pricing terms were disclosed.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

This article appears in: News Headlines IPOs
Referenced Stocks:

More from Renaissance Capital


Renaissance Capital

Renaissance Capital

Follow on:

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by